Daniel C. Smith

Chief Scientific Officer, That's Nice

Professor Daniel C. Smith has extensive experience in biochemistry, molecular cell biology, and leadership roles within the scientific and business sectors. His career highlights include serving as the Chief Scientific Officer at That’s Nice, where he promotes collaboration for scientific advancements in advanced therapeutics. Additionally, as the Owner and Principal Consultant of BIOCODEX Limited, he offers strategic support to clients in innovation and technology.

During his time with the UK vaccines taskforce and the Oxford University Vaccine Trial Group, he played a key role in the technology transfer and scale-up of the ChAdOx COVID19 vaccine. His contributions to Cobra/Cognate and as the Executive Director of Global Cell & Gene Therapy Portfolio at Charles River further demonstrate his expertise in driving innovation and strategic partnerships in the advanced therapy sector.

Daniel’s honorary professorships at the University of Warwick and the University of Kent, along with his hands-on experience in leadership positions and business strategy, showcase his versatile skills and knowledge within regulated environments globally. Overall, his background and achievements reflect a strong commitment to advancing scientific and technical developments in the field of biotechnology and advanced therapies.